Cuvposa Approval History
FDA Approved: Yes (First approved July 28, 2010)
Brand name: Cuvposa
Generic name: glycopyrrolate
Dosage form: Oral Solution
Company: Shionogi Pharma Inc.
Treatment for: Chronic Drooling in Children
Cuvposa (glycopyrrolate) oral solution is an anticholinergic for the treatment of chronic severe drooling caused by neurologic disorders in children.
Development History and FDA Approval Process for Cuvposa
|Jul 29, 2010||FDA Approves Cuvposa for Chronic Drooling in Children|
|Sep 29, 2009||Sciele Pharma Submits New Drug Application to FDA for Glycopyrrolate Oral Solution, a Treatment for Chronic, Moderate-to-Severe Drooling in Pediatric Patients|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.